Study on the Treatment of Degenerative Lumbar Spine Stenosis With a Percutaneous Interspinous Implant
Primary Purpose
Lumbar Spinal Stenosis
Status
Terminated
Phase
Phase 4
Locations
Germany
Study Type
Interventional
Intervention
Spacer
physiotherapy
Sponsored by
About this trial
This is an interventional treatment trial for Lumbar Spinal Stenosis focused on measuring PIDLSS, Spacer
Eligibility Criteria
Inclusion Criteria:
- Male or female over 50 years of age
- One, two, or three segment degenerative lumbar spinal stenosis (DLSS)
- Symptoms of radiographically confirmed DLSS like leg, buttock, or groin pain with or without back pain and absence of a peripheral motoric deficit
- Pain relief in inclination or sitting
- Ability to walk over a distance of 50 m
- Unsuccessful conservative therapy for 3 months under outpatient conditions
- Informed consent
Exclusion Criteria:
- Fixed motoric deficit
- Cauda equina syndrome
- Previous surgery of the lumbar spine
- Severe osteoporosis of the vertebrae and/or of the hip
- Spondylolisthesis more severe than Meyerding I (on scale of I-IV)
- Metastasis of the vertebrae
- Mentally disabled persons
Sites / Locations
- University Hospital Cologne
- University Hospital of Cologne
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Other
Arm Label
Spacer
physiotherapy
Arm Description
Implantation of a percutaneously implanted interspinous device ("spacer")
The control group will receive at least physiotherapy and physical therapy (e.g. massage and fango). Under inpatient conditions therapy will last for seven days. After discharge physical therapy has to be continued for 5 weeks. A schedule will ensure the consistency of the physical therapy. The inpatient-treatment can be repeated every 6 months if necessary.
Outcomes
Primary Outcome Measures
Changes in subscores for bodily pain and physical function on SF-36
Secondary Outcome Measures
Symptoms severity by applying the Zurich Claudication Questionaire (ZCQ)
Physical function by applying ZCQ
Post-treatment patient satisfaction by applying ZCQ
General health status (Quality of life) by applying SF-36
Measurement of walking distance
Full Information
NCT ID
NCT01057641
First Posted
January 26, 2010
Last Updated
November 4, 2016
Sponsor
University of Cologne
1. Study Identification
Unique Protocol Identification Number
NCT01057641
Brief Title
Study on the Treatment of Degenerative Lumbar Spine Stenosis With a Percutaneous Interspinous Implant
Official Title
A Clinical Study on the Treatment of Degenerative Lumbar Spine Stenosis With a Percutaneous Interspinous Implant in Comparison With the Best Non-operative Treatment of Lumbar Spine Stenosis
Study Type
Interventional
2. Study Status
Record Verification Date
November 2016
Overall Recruitment Status
Terminated
Why Stopped
low enrollment
Study Start Date
March 2011 (undefined)
Primary Completion Date
May 2016 (Actual)
Study Completion Date
June 2018 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Cologne
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Neurogenic intermittent claudication is a specific symptom complex occurring in patients with lumbar spinal stenosis. Characteristic of this disease is the occurrence of increasing leg, buttock or groin pain with or without lower back pain when walking a certain distance or reclining. Bending forward or sitting leads to a rapid pain relief. Lumbar spinal stenosis is defined as a reduction of the diameter of the spinal canal. The mechanism leading to stenosis is a remodeling and overgrowth of the spinal canal with osteophyte formation. Any loss of tissue or decrease of the disc height results in a relative laxity of the ligament structures and accelerates the degeneration of the spinal joints. As a therapy option, conservative therapy with oral analgesics and physical therapy is considered. This treatment can be intensified by adding epidural pain treatment. Is the conservative treatment not successful surgical intervention is necessary. In patients over 65 years of age operative decompression of the lumbar spinal stenosis constitutes the most common surgical operation of the spine. A relatively new therapy alternative is the interspinous process decompression (IPD). Studies have shown that the IPDs prevent narrowing of the spinal canal and neural foramens. The study is intended as a randomised, monocentre study to investigate the safety and the benefit of a minimally invasive percutaneous IPD-device in comparison with the best non-surgical operative treatment of lumbar spinal stenosis.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lumbar Spinal Stenosis
Keywords
PIDLSS, Spacer
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
22 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Spacer
Arm Type
Experimental
Arm Description
Implantation of a percutaneously implanted interspinous device ("spacer")
Arm Title
physiotherapy
Arm Type
Other
Arm Description
The control group will receive at least physiotherapy and physical therapy (e.g. massage and fango). Under inpatient conditions therapy will last for seven days. After discharge physical therapy has to be continued for 5 weeks. A schedule will ensure the consistency of the physical therapy. The inpatient-treatment can be repeated every 6 months if necessary.
Intervention Type
Procedure
Intervention Name(s)
Spacer
Other Intervention Name(s)
PIDLSS
Intervention Description
Implantation of a percutaneously implanted interspinous device (spacer)
Intervention Type
Other
Intervention Name(s)
physiotherapy
Other Intervention Name(s)
PIDLSS
Intervention Description
physiotherapy
Primary Outcome Measure Information:
Title
Changes in subscores for bodily pain and physical function on SF-36
Time Frame
baseline, 6 months
Secondary Outcome Measure Information:
Title
Symptoms severity by applying the Zurich Claudication Questionaire (ZCQ)
Time Frame
baseline, 6 months
Title
Physical function by applying ZCQ
Time Frame
baseline, 6 months
Title
Post-treatment patient satisfaction by applying ZCQ
Time Frame
baseline, 6 months
Title
General health status (Quality of life) by applying SF-36
Time Frame
baseline, 6 months
Title
Measurement of walking distance
Time Frame
baseline, 6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Male or female over 50 years of age
One, two, or three segment degenerative lumbar spinal stenosis (DLSS)
Symptoms of radiographically confirmed DLSS like leg, buttock, or groin pain with or without back pain and absence of a peripheral motoric deficit
Pain relief in inclination or sitting
Ability to walk over a distance of 50 m
Unsuccessful conservative therapy for 3 months under outpatient conditions
Informed consent
Exclusion Criteria:
Fixed motoric deficit
Cauda equina syndrome
Previous surgery of the lumbar spine
Severe osteoporosis of the vertebrae and/or of the hip
Spondylolisthesis more severe than Meyerding I (on scale of I-IV)
Metastasis of the vertebrae
Mentally disabled persons
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thomas Kaulhausen, MD
Organizational Affiliation
University Hospital of Cologne
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital Cologne
City
Cologne
State/Province
NRW
ZIP/Postal Code
50931
Country
Germany
Facility Name
University Hospital of Cologne
City
Cologne
ZIP/Postal Code
50924
Country
Germany
12. IPD Sharing Statement
Learn more about this trial
Study on the Treatment of Degenerative Lumbar Spine Stenosis With a Percutaneous Interspinous Implant
We'll reach out to this number within 24 hrs